Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Clinical trial NCT01566604 · COMPLETED
Trial details
- NCT number
- NCT01566604
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-06-01
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.